Cellares
PrivateLast Round
Series D
Jun 18, 2026
Est. Valuation
$1.44B
Total Funding Raised
$1.01B
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cellares is a biotechnology company that provides integrated development and manufacturing solutions for cell therapies through its automated IDMO Smart Factory network.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing, Biotech Equipment, Warehouse Automation
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellares Comparables
Compare Cellares with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ori Biotech | 83% | |
| Cellular Origins | 81% | |
| Miltenyi Biotec | 80% |
Cellares Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 18, 2026 | ||||
| Series D | Jan 28, 2026 | ||||
| IPO | Dec 1, 2025 | ||||
| Series C | Aug 23, 2023 | ||||
| Series B | May 5, 2021 | ||||
Series A | Aug 1, 2019 |
Key People
Founding team and executive leadership
Cellares Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series A |
| Prime Radiant Partners | Series D |
| S32 | Series C |
| Skyviews Life Science | Series B |
| Duquesne Family Office | Series D |
| Koch-ventures.com | Series C |
| EDBI | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 65% MoM, reaching 32.2K.
- Jun 18, 2026
$257M round raised
Cellares Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cellares's valuation, stock price, and market status.
Is Cellares a public or private company?
Cellares is a private company.
What is the current stock price of Cellares?
Cellares is a private company with no public stock price. No recent secondary market data is available.
How much is Cellares worth (valuation)?
Cellares's valuation is estimated at $1.4B based on funding round data.
Can I buy Cellares stock?
Cellares shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cellares's last funding round?
Cellares's most recent funding round was Series D on June 18, 2026.
Who are the main investors in Cellares?
Key investors in Cellares include Koch-ventures.com, Eclipse Ventures, Koch Disruptive Technologies, BlackRock, Decheng Capital.
Will Cellares IPO soon?
No public IPO plans have been announced for Cellares.
How can I track Cellares secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellares's secondary market activity and sign up for updates.